tiprankstipranks
Biohaven Ltd. (BHVN)
NYSE:BHVN
US Market
BHVN
Biohaven Ltd.
RESEARCH TOOLSreports
Want to see BHVN full AI Analyst Report?

Biohaven Ltd. (BHVN) Stock News & Sentiment

856 Followers
Biohaven: Hold Rating Reiterated as Clinical and Competitive Uncertainties Persist; Price Target Maintained at $10
Premium
Ratings
Biohaven: Hold Rating Reiterated as Clinical and Competitive Uncertainties Persist; Price Target Maintained at $10
7d ago
BHVN
Biohaven Warns of Broad Operational, Financial and Market Risks, Affirms Overall Risk Profile Matches Prior 10-K Disclosures
Premium
Company Announcements
Biohaven Warns of Broad Operational, Financial and Market Risks, Affirms Overall Risk Profile Matches Prior 10-K Disclosures
13d ago
BHVN
Biohaven Expands At-The-Market Equity Offering Program
Premium
Company Announcements
Biohaven Expands At-The-Market Equity Offering Program
14d ago
8K
BHVN
Biohaven: Buy Rating Reiterated as Analyst Sees Multiple Pipeline Catalysts and Maintains $21 Price Target
Premium
Ratings
Biohaven: Buy Rating Reiterated as Analyst Sees Multiple Pipeline Catalysts and Maintains $21 Price Target
14d ago
BHVN
Biohaven: Buy Rating Reiterated as Pipeline De‑Risking Builds Ahead of Key 2026 Readouts; $30 Price Target Maintained
Premium
Ratings
Biohaven: Buy Rating Reiterated as Pipeline De‑Risking Builds Ahead of Key 2026 Readouts; $30 Price Target Maintained
14d ago
BHVN
Biohaven Price Target Trimmed to $12 as Analyst Maintains Hold Amid Balanced Pipeline Upside and Financing Risks
Premium
Ratings
Biohaven Price Target Trimmed to $12 as Analyst Maintains Hold Amid Balanced Pipeline Upside and Financing Risks
14d ago
BHVN
Biohaven Shareholders Back Board, Auditor and Executive Pay
Premium
Company Announcements
Biohaven Shareholders Back Board, Auditor and Executive Pay
15d ago
8K
BHVN
More BHVN News >

BHVN News on the Web

Why Biohaven Stock Crushed it on Monday
The Motley Fool
Neutral
Hemmati eyed for top vaccine and gene therapy regulator role, Bloomberg says
TipRanks News
Neutral
Biohaven initiated with a Buy at Canaccord
TipRanks News
Bullish
Biohaven price target raised to $17 from $14 at Citi
TipRanks News
Bullish
Biohaven Ltd. (BHVN) Gets a Buy from Piper Sandler
TipRanks News
Bullish
Analysts’ Top Healthcare Picks: ACADIA Pharmaceuticals (ACAD), Biohaven Ltd. (BHVN)
TipRanks News
Neutral
Biohaven Stock Down 70% but One Fund's New $6 Million Bet Signals Turnaround Potential
The Motley Fool
Bearish
This $8.9 Million Buy Targets a Stock Down 68% With $322 Million in Cash
The Motley Fool
Bearish

News Score - Last 7 Days

Not enough data to generate a sentiment score
BHVN
Sector Average
Media Buzz
This Week2 articles
Weekly Average4.25 articles
News Sentiment
This Week59%
Sector Average78%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is BHVN’s Media Buzz Sentiment?
2 articles about BHVN were published this week. In an average week, 4.25 articles are published.
    What is BHVN’s weekly average amount of articles?
    In an average week, 4.25 articles about BHVN are published.
      What is BHVN’s News Sentiment?
      59% of articles about BHVN were positive this week, compared to its sector average of 78%.
        Healthcare Stocks that are Trending in the News
        DOCSDoximity
        AVAHAveanna Healthcare Holdings
        AQSTAquestive Therapeutics
        HTFLHeartFlow, Inc.
        PGENPrecigen
        Showing the stocks with the most bullish news sentiment over the past week